0 slides
Return to Slide Library
Slides
Add Presentation to Slide Tray
Presentation: Angiotensin-Converting Enzyme Inhibitors (ACEIs), Angiotensin II Receptor Antagonists (ARBs), or Direct Renin Inhibitors (DRI) for Adults With Hypertension
Angiotensin-Converting Enzyme Inhibitors (ACEIs), Angiotensin II Receptor Antagonists (ARBs), or Direct Renin Inhibitors (DRI) for Adults with Hypertension
Background: Pharmacological Blockade of the Renin-Angiotensin System
Background: Drugs Targeting The Renin System May Not Be Clinically Equivalent
Agency for Healthcare Research and Quality (AHRQ) Comparative Effectiveness Review (CER) Development
Rating the Strength of Evidence From the CER
Number of Studies Evaluating Various Treatment Options
Evidence of Benefits: Blood Pressure-Lowering Effects
Evidence of Benefits: Clinical Outcomes
Evidence on Adverse Effects
Your slide tray is being processed.